Mangalam Drugs spurts after reporting turnaround numbers in Q1

Mangalam Drugs & Organics was locked at 5% upper circuit at Rs 78.25 at 14:42 IST on BSE after the company reported net profit of Rs 3.05 crore in Q1 June 2015 compared with net loss of Rs 0.20 crore in Q1 June 2014.

The Q1 result was announced during market hours today, 4 August 2015.

Meanwhile, the S&P BSE Sensex was down 104.82 points or 0.37% at 28,082.24.

On BSE, so far 1.05 lakh shares were traded in the counter as against average daily volume of 1.19 lakh shares in the past one quarter.

The stock hit a low of Rs 72.75 so far during the day. The stock had hit a 52-week high of Rs 86.45 on 11 June 2015. The stock had hit a 52-week low of Rs 12.50 on 1 August 2014.

The stock had outperformed the market over the past one month till 3 August 2015, surging 32.3% compared with Sensex's 0.34% rise. The scrip had also outperformed the market in past one quarter, jumping 87.55% as against Sensex's 4.35% rise.

The small-cap company has equity capital of Rs 13.18 crore. Face value per share is Rs 10.

Mangalam Drugs & Organics' total net income from operations rose 80.11% to Rs 69.58 crore in Q1 June 2015 over Q1 June 2014.

Mangalam Drugs & Organics is engaged in the manufacture of active pharmaceutical ingredients (APIs).

Powered by Capital Market - Live News